201 Results for "

alpha-synuclein

" in MedChemExpress (MCE) Product Catalog:
Products (201)

201 Results for "alpha-synuclein" in MCE Product Catalog:

Cat. No.: HY-P3140A
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (61-75) TFA is the 61-75 fragment of α-Synuclein. α-Synuclein is an abundant neuronal protein that is highly enriched in presynaptic nerve terminals. α-Synuclein is a potential biomarker for Parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-P4704A
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (61-95) (human) TFA is the hydrophobic core region of α-synuclein, and induces neuronal cell death. α-Synuclein (61-95) (human) TFA can be used for research of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-157308
CAS No.: 3050715-65-3
Purity:  99.85%
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein inhibitor 10 (compound a8) inhibits the activity of α-Syn aggregation with low IC50 value (1.08 μM). α-Synuclein inhibitor 10 exhibits good binding affinity to α-Syn residues. α-Synuclein inhibitor 10 can be used in the research of Parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-135902
CAS No.: 502139-01-7
Synonyms: NSC 377363
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease

Synucleozid (NSC 377363) is a potent inhibitor of the SNCA mRNA that encodes α-synuclein protein. Synucleozid selectively targets the α-synuclein mRNA 5′ UTR at the designed IRE site, decreases the amount of SNCA mRNA loaded into polysomes and thereby inhibits SNCA translation. Synucleozid has the potential for the investigation of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-P3140
CAS No.: 440645-08-9
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (61-75) is the 61-75 fragment of α-Synuclein. α-Synuclein is an abundant neuronal protein that is highly enriched in presynaptic nerve terminals. α-Synuclein is a potential biomarker for Parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-178920
CAS No.: 676458-63-2
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein-IN-17 (Compound 10) is an α-Synuclein inhibitor, with an IC50 value of 9 μM. α-Synuclein-IN-17 exhibits potent inhibitory activity against both in-vitro assembled asyn fibrils and LBD brain tissue-amplified asyn fibrils. α-Synuclein-IN-17 can be used for the study of Parkinson's disease (PD) and Lewy Body Disease (LBD) .
loading...
    loading...
Cat. No.: HY-163145
CAS No.: 3095291-54-3
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein inhibitor 11 (compound 1) is a selective α-synuclein (α-syn) oligomer formation inhibitor. α-Synuclein inhibitor 11 does not inhibits tau 4R (isoforms 0N4R, 2N4R) or p-tau (isoform 1N4R). α-Synuclein inhibitor 11 can be used for Parkinson's disease (PD) research .
loading...
    loading...
Cat. No.: HY-176925
CAS No.: 3056154-68-5
Target:  

α-synuclein Amyloid-β

Research Areas:  

Neurological Disease

α-Synuclein aggregate binder 2 (Compound 1) is a specific alpha-synuclein binder with a Ki of 1.6 nM. α-Synuclein aggregate binder 2 has a weak binding affinity for β-amyloid aggregates with a Ki of 295 nM. α-Synuclein aggregate binder 2 can be used as a tracer in Parkinson's disease .
loading...
    loading...
Cat. No.: HY-B0512A
CAS No.: 127-58-2
Synonyms: RP2632 sodium
Sulfamerazine (RP2632) sodium is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine sodium inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine sodium inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine sodium can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
Cat. No.: HY-P10360
CAS No.: 2816095-52-8
Target:  

α-synuclein

Research Areas:  

Neurological Disease

Tat-βsyn-degron is an α-synuclein knockdown peptide that effectively degrades α-synuclein protein via the proteasome pathway. Tat-βsyn-degron effectively reduces α-synuclein protein levels in primary rat cortical neuron cultures. In a Parkinson's mouse toxicity model, Tat-βsyn-degron can alleviate parkinsonian toxin-induced neuronal damage and movement disorders .
loading...
    loading...
Cat. No.: HY-177647
CAS No.: 2411937-33-0
Synonyms: BIIB-101; ION-464
Target:  

α-synuclein

Research Areas:  

Neurological Disease

Movronersen is an antisense oligonucleotide targeted to α-synuclein.
loading...
    loading...
Cat. No.: HY-115038
CAS No.: 312-63-0
Purity:  99.50%
Target:  

α-synuclein

Research Areas:  

Neurological Disease

ELN484228 is a blocker of α-synuclein which is a key protein in Parkinson’s disease.
loading...
    loading...
Cat. No.: HY-175737
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-synuclein-IN-16 (Compound H1) is a α-synuclein inhibitor. α-synuclein-IN-16 significantly inhibits the secondary nucleation in α-synuclein aggregation. α-synuclein-IN-16 can be used for Parkinson’s disease research .
loading...
    loading...
Cat. No.: HY-P5043
CAS No.: 2243206-99-5
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (67-78) (human) is the 67-78 fragment of α-Synuclein. α-Synuclein (67-78) (human) promotes network activity drive and blocks KCl-induced syt1L-ab uptake .
loading...
    loading...
Cat. No.: HY-N15613
CAS No.: 408324-13-0
α-Synuclein inhibitor 14 (Compound 3) is a diarylheptanoid that can be isolated from Alpinia officinarum. α-Synuclein inhibitor 14 can inhibit the aggregation of α-synuclein, with an inhibition rate of 72.4% at a concentration of 10 μM. α-Synuclein inhibitor 14 can be used in the research of neurodegenerative diseases such as Parkinson's disease .
loading...
    loading...
Cat. No.: HY-P4704
CAS No.: 154040-19-4
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (61-95) (human) is the hydrophobic core region of α-synuclein, and induces neuronal cell death. α-Synuclein (61-95) (human) can be used for research of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-175308
CAS No.: 414880-30-1
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein inhibitor 15 (Compound 1) is an inhibitor targeting the fibrillation growth of α-synuclein (IC50=18 μM). α-Synuclein inhibitor 15 is promising for research of neurodegenerative diseases, such as Parkinson's disease (PD) and Lewy body dementia (LBD) .
loading...
    loading...
Cat. No.: HY-N10306
CAS No.: 3034046-94-8
Category:  

Animals Steroids

Target:  

α-synuclein

Sycosterol A is a sterol-based α-synuclein (α-syn) inhibitor that targets α-synuclein aggregates and inhibits α-synuclein aggregation. Sycosterol A can be used in the study of anti-neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-177647A
Synonyms: BIIB-101 sodium; ION-464 sodium
Target:  

α-synuclein

Research Areas:  

Neurological Disease

Movronersen sodium is an antisense oligonucleotide targeted to α-synuclein.
loading...
    loading...
Cat. No.: HY-P5041
CAS No.: 2170181-52-7
Target:  

α-synuclein

Research Areas:  

Neurological Disease

α-Synuclein (34-45) (human) is the 34-45 fragment of α-Synuclein. α-Synuclein is an abundant neuronal protein that is highly abundant in presynaptic nerve terminals. α-Synuclein is a Parkinson's disease (PD) biomarker .
loading...
    loading...